Diagnosis of Cardiac Amyloidosis in South Asia: Need for a Collaborative Approach from Researchers and Clinicians

Shreya Ghosh1, Dibbendhu Khanra2, Chayanika Kala3

  • 1Department of Biological Sciences and Bioengineering; Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Uttar Pradesh, India; Department of Chemistry and Chemical Biology Northeastern University, Boston, Massachusetts, United States, Corresponding Author.

Insights

Accurate diagnosis of cardiac amyloidosis (CA) is now more possible due to new methods. Early CA detection is crucial for South Asian patients, especially during the COVID-19 pandemic, to improve outcomes.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Public Health

Background:

  • Cardiac amyloidosis (CA) diagnosis has improved with recent advancements.
  • Cardiovascular diseases are rising in South Asia, with many undiagnosed CA cases.
  • Amyloidosis patients are susceptible to SARS-CoV-2, necessitating prompt CA diagnosis and management during the COVID-19 pandemic.

Purpose of the Study:

  • To review recent diagnostic approaches for cardiac amyloidosis (CA).
  • To outline adapted treatment options for CA.
  • To present future initiatives for diagnosing CA in the South Asian population.

Main Methods:

  • Literature review of recent diagnostic and treatment strategies for CA.
  • Analysis of CA prevalence and diagnostic challenges in South Asia.
  • Discussion of future diagnostic initiatives.

Main Results:

  • New diagnostic tools enhance the accuracy of CA detection.
  • The review covers current and future strategies for CA diagnosis and management.
  • Collaborative adoption of these approaches can improve CA diagnosis in India and South Asia.

Conclusions:

  • Enhanced diagnostic capabilities offer improved accuracy for cardiac amyloidosis.
  • Prompt diagnosis and management of CA are vital, particularly in the context of rising cardiovascular diseases and SARS-CoV-2 susceptibility.
  • Future initiatives and collaborative efforts are essential for accurate CA diagnosis in the South Asian population.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22